12.02.2019 - 13.02.2019The Colonnade Boston Hotel, 120 Huntington Avenue, 02116 Boston, USA
Time: 8:00 am - 4:00 pm
Conference themes As scientific breakthroughs and novel discoveries reveal the causal link and interface between metabolic pathways and immune cell function, the inaugural Immunometabolism Drug Development Summit 2019 is dedicated to help large pharma, biotech and academia translate basic immunometabolism research into a novel class of clinically safe and effective therapeutics for immune-mediated diseases.
Professional congress organizer (PCO) Hanson Wade
Notes Speakers: Laurence Turka (Rheos Medicines), Robert Wild (Dracen Pharmaceuticals), Paul-Peter Tak (Levicept and Sitryx Therapeutics), Lauriane Cabon (Roche), Mateusz Nowak (Selvita)